NasdaqGS - Delayed Quote USD
Moderna, Inc. (MRNA)
26.56
-0.37
(-1.37%)
At close: May 30 at 4:00:02 PM EDT
27.49
+0.93
+(3.50%)
Pre-Market: 8:25:35 AM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-3,052,000
-3,004,000
-3,118,000
4,981,000
13,620,000
Investing Cash Flow
2,561,000
1,949,000
4,206,000
-5,176,000
-8,523,000
Financing Cash Flow
46,000
56,000
-1,377,000
-3,448,000
-873,000
End Cash Position
1,626,000
1,929,000
2,928,000
3,217,000
6,860,000
Income Tax Paid Supplemental Data
--
197,000
--
2,729,000
480,000
Interest Paid Supplemental Data
--
24,000
39,000
25,000
14,000
Capital Expenditure
-982,000
-1,051,000
-707,000
-400,000
-284,000
Issuance of Capital Stock
54,000
66,000
46,000
65,000
124,000
Repayment of Debt
--
--
--
--
-140,000
Repurchase of Capital Stock
--
0
-1,153,000
-3,329,000
-857,000
Free Cash Flow
-4,034,000
-4,055,000
-3,825,000
4,581,000
13,336,000
12/31/2021 - 12/7/2018
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
NVAX Novavax, Inc.
7.34
+2.09%
REGN Regeneron Pharmaceuticals, Inc.
490.28
-19.01%
SMMT Summit Therapeutics Inc.
18.22
-30.50%
BNTX BioNTech SE
95.81
-4.43%
NTLA Intellia Therapeutics, Inc.
6.87
-7.79%
TNXP Tonix Pharmaceuticals Holding Corp.
39.78
-5.33%
CRSP CRISPR Therapeutics AG
36.29
-1.33%
RXRX Recursion Pharmaceuticals, Inc.
4.1800
-6.07%
VKTX Viking Therapeutics, Inc.
26.80
-4.83%
SRPT Sarepta Therapeutics, Inc.
37.60
-2.62%